Evidence map›Paper›PMID 32785664›Full record

ArticleGenome biology and evolution2020

Human Spermatogenesis Tolerates Massive Size Reduction of the Pseudoautosomal Region.

Maki Fukami, Yasuko Fujisawa, Hiroyuki Ono, Tomoko Jinno, Tsutomu Ogata

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genome biology and evolution, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maki FukamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Yasuko FujisawaDepartment of Pediatrics, Hamamatsu University School of Medicine, Japan.
Hiroyuki OnoDepartment of Pediatrics, Hamamatsu University School of Medicine, Japan.
Tomoko JinnoDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Tsutomu OgataDepartment of Pediatrics, Hamamatsu University School of Medicine, Japan.
Hamamatsu University School of Medicine · JPNational Center For Child Health and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian male meiosis requires homologous recombination between the X and Y chromosomes. In humans, such recombination occurs exclusively in the short arm pseudoautosomal region (PAR1) of 2.699 Mb in size. Although it is known that complete deletion of PAR1 causes spermatogenic arrest, no studies have addressed to what extent male meiosis tolerates PAR1 size reduction. Here, we report two families in which PAR1 partial deletions were transmitted from fathers to their offspring. Cytogenetic analyses revealed that a ∼400-kb segment at the centromeric end of PAR1, which accounts for only 14.8% of normal PAR1 and 0.26% and 0.68% of the X and Y chromosomes, respectively, is sufficient to mediate sex chromosomal recombination during spermatogenesis. These results highlight the extreme recombinogenic activity of human PAR1. Our data, in conjunction with previous findings from animal studies, indicate that the minimal size requirement of mammalian PARs to maintain male fertility is fairly small.

Indexed as

Homologous RecombinationAdultAnimalsBase SequenceFemaleFertilityHumansMalePseudoautosomal RegionsSequence DeletionShort Stature Homeobox ProteinSpermatogenesisShort Stature Homeobox ProteinSHOX protein, humancrossoverhomologous recombinationpseudoautosomal regionsex chromosomeSHOX

Identifiers

PMID32785664
PMCPMC7608489
OpenAlexW3054596212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.